Vynleads, Inc. — Cyborg Score 3/10

Weak
Digital health and chronic disease management

Strategic Profile

The company's flagship program, Done With Diabetes (DWD), offers personalized wellness strategies aimed at managing and preventing chronic diseases through education and lifestyle modifications. Vynleads offers Lifestyle Blueprint, a digital guide that provides dietary recommendations for a very low calorie eight-week diet, as well as nutritional information, sells nutritional supplements, and monthly subscriptions to proprietary newsletters that cover healthy living-related topics through online channels.

Cyborg Score Rationale

As of April 27, 2026, the company has 1 employee. The company operates at a micro scale with minimal analyst coverage and limited liquidity on OTC markets, presenting substantial execution risk and capital constraints.

Top Insights

  • As of April 2026, the company operates with only 1 employee
  • Market capitalization is approximately $4.6 million
  • The company does not pay dividends to shareholders
  • Vynleads is covered by 0 analysts with no analyst estimates available

Named Competitors

  • Livongo Health — Chronic disease management and telehealth platform
  • Omada Health — Digital diabetes and chronic disease prevention programs
  • Glooko — Diabetes data management and analytics platform

Open the full interactive Vynleads, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →